Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hyeonggaeyeongyo-tang (HYT) is a traditional East Asian herbal medicine formulation used for centuries to treat inflammatory conditions of the upper respiratory tract and skin, such as chronic rhinitis, rhinosinusitis, and acne. The formula is a complex mixture of multiple herbal ingredients, typically including *Schizonepeta tenuifolia*, *Bupleurum falcatum*, *Cnidium officinale*, *Angelica gigas*, and *Paeonia lactiflora*, among others. It is believed to exert therapeutic effects through synergistic anti-inflammatory and immunomodulatory mechanisms, including the inhibition of inflammatory cytokines and allergic mediators. Kyung Hee University Hospital at Gangdong has conducted Phase 4 clinical trials (e.g., NCT02477293) to evaluate its safety and efficacy specifically for chronic rhinitis, utilizing Korean medicine pattern identification to tailor treatment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hyeonggaeyeongyo-tang.